CME Group Inc (CME) Given Average Rating of “Hold” by Brokerages

CME Group Inc (NASDAQ:CME) has received a consensus recommendation of “Hold” from the seventeen brokerages that are presently covering the company, MarketBeat reports. Two research analysts have rated the stock with a sell recommendation, nine have given a hold recommendation and six have issued a buy recommendation on the company. The average 1 year price objective among brokerages that have covered the stock in the last year is $193.15.

Several analysts recently issued reports on the stock. BidaskClub downgraded shares of CME Group from a “sell” rating to a “strong sell” rating in a report on Friday, March 22nd. Zacks Investment Research downgraded shares of CME Group from a “hold” rating to a “sell” rating in a report on Tuesday, April 9th. Barclays decreased their price objective on shares of CME Group from $210.00 to $193.00 and set an “overweight” rating for the company in a report on Tuesday, March 26th. Sanford C. Bernstein reaffirmed an “outperform” rating and set a $210.00 price objective on shares of CME Group in a report on Friday, February 15th. Finally, ValuEngine downgraded shares of CME Group from a “buy” rating to a “hold” rating in a report on Wednesday, March 20th.

In other CME Group news, Director Jeffrey M. Bernacchi sold 10,087 shares of the stock in a transaction on Tuesday, February 26th. The shares were sold at an average price of $177.94, for a total value of $1,794,880.78. Following the completion of the sale, the director now directly owns 42,004 shares of the company’s stock, valued at approximately $7,474,191.76. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, insider Kathleen M. Cronin sold 8,340 shares of the stock in a transaction on Thursday, March 14th. The shares were sold at an average price of $167.54, for a total transaction of $1,397,283.60. Following the completion of the sale, the insider now directly owns 41,604 shares of the company’s stock, valued at $6,970,334.16. The disclosure for this sale can be found here. Over the last three months, insiders sold 28,489 shares of company stock valued at $4,948,996. Insiders own 1.20% of the company’s stock.

A number of institutional investors have recently modified their holdings of the business. BlackRock Inc. raised its stake in shares of CME Group by 8.2% in the 4th quarter. BlackRock Inc. now owns 24,250,752 shares of the financial services provider’s stock valued at $4,562,052,000 after buying an additional 1,828,640 shares in the last quarter. Oregon Public Employees Retirement Fund raised its stake in shares of CME Group by 18,502.9% in the 4th quarter. Oregon Public Employees Retirement Fund now owns 16,220,459 shares of the financial services provider’s stock valued at $86,000 after buying an additional 16,133,266 shares in the last quarter. FMR LLC raised its stake in shares of CME Group by 114.7% in the 4th quarter. FMR LLC now owns 6,198,088 shares of the financial services provider’s stock valued at $1,165,984,000 after buying an additional 3,310,989 shares in the last quarter. Geode Capital Management LLC raised its stake in shares of CME Group by 12.9% in the 4th quarter. Geode Capital Management LLC now owns 4,715,269 shares of the financial services provider’s stock valued at $885,776,000 after buying an additional 537,917 shares in the last quarter. Finally, Northern Trust Corp raised its stake in shares of CME Group by 7.6% in the 4th quarter. Northern Trust Corp now owns 4,169,737 shares of the financial services provider’s stock valued at $784,411,000 after buying an additional 293,957 shares in the last quarter. 84.84% of the stock is owned by hedge funds and other institutional investors.

CME stock traded down $0.56 during trading hours on Tuesday, hitting $176.36. The company’s stock had a trading volume of 2,021,786 shares, compared to its average volume of 1,617,974. The company has a quick ratio of 1.01, a current ratio of 1.01 and a debt-to-equity ratio of 0.15. The company has a market capitalization of $63.10 billion, a price-to-earnings ratio of 25.86, a P/E/G ratio of 3.60 and a beta of 0.29. CME Group has a 12 month low of $153.90 and a 12 month high of $197.08.

CME Group (NASDAQ:CME) last posted its earnings results on Thursday, February 14th. The financial services provider reported $1.77 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.75 by $0.02. The company had revenue of $1.24 billion during the quarter, compared to the consensus estimate of $1.22 billion. CME Group had a net margin of 45.53% and a return on equity of 9.85%. The company’s revenue for the quarter was up 37.4% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.12 earnings per share. On average, research analysts expect that CME Group will post 6.81 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which was paid on Monday, March 25th. Shareholders of record on Friday, March 8th were issued a $0.75 dividend. The ex-dividend date was Thursday, March 7th. This is an increase from CME Group’s previous quarterly dividend of $0.70. This represents a $3.00 dividend on an annualized basis and a yield of 1.70%. CME Group’s dividend payout ratio is 43.99%.

About CME Group

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.

Further Reading: Outstanding Shares, Buying and Selling Stocks

Analyst Recommendations for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.